• EE157 Assessing the Cost-Effectiveness of Sodium Phenylbutyrate/Taurursodiol and Oral Edaravone in the Treatment of Amyotrophic Lateral Sclerosis

    Jun 1, 2024, 00:00

  • HSD48 US Infusion Center Capacity to Accommodate Anti-Amyloid Treatments for Alzheimer’s Disease: A Quantitative Survey

    Jun 1, 2024, 00:00

  • EE412 Real-World Cost-Effectiveness Analysis of Ustekinumab-Based Therapies Vs Non-Biologic Therapies for Moderate to Severe Crohn’s Disease in Chinese Population

    Jun 1, 2024, 00:00

  • PCR144 Generating Uptake Probabilities from Discrete-Choice Experiment-Derived Preferences for Application in Patient-Centered Value Assessment

    Jun 1, 2024, 00:00

  • PCR23 The Effect of Obstetric Interventions on Breastfeeding: A Cross-Sectional Study

    Jun 1, 2024, 00:00

  • CO124 Association Between Quality of Life and Viral Load Among People With HIV in the Current Antiretroviral Era

    Jun 1, 2024, 00:00

  • SA30 Symptom Burden and Healthcare Resource Use in Claudin 18.2+ (CLDN18.2+), HER2− Patients With Locally Advanced (LA) Unresectable or Metastatic Gastric or Gastroesophageal Junction (mG/GEJ) Adenocarcinoma

    Jun 1, 2024, 00:00

  • HPR61 Impact of Changes in US Medicaid Reimbursement for Long-Acting Reversible Contraceptives in the Immediate Postpartum Period

    Jun 1, 2024, 00:00

  • EE450 JAV-RARAS: Valoriza a Jornada De Cuidado De Pacientes Com Mucopolissacaridose Tipo 2: Resultados Preliminares De Um Estudo Real No Sistema Único De Saúde (SUS)

    Jun 1, 2024, 00:00

  • RWD129 Trends in GLP-1 Receptor Agonist Dispensing Among US Patients Without Type 2 Diabetes Using Real World Data

    Jun 1, 2024, 00:00

  • EE362 Analysis of the Cost of Pharmacological Care for Patients With Type 2 Diabetes Mellitus on the Colombian Atlantic Coast: 2019-2022 Risk Cohort Analysis

    Jun 1, 2024, 00:00

  • EPH54 Enhancing BMI Data Accuracy: A Comparison of Claims and Electronic Health Records (EHR) Database

    Jun 1, 2024, 00:00

  • EPH75 Herpes Zoster Risk Among Immunocompromised Adults in the United States: A Retrospective Cohort Analysis

    Jun 1, 2024, 00:00

  • EE340 Real-World Healthcare Resource Utilization and Costs of Patients with Alzheimer’s Disease By Stage: A Retrospective Observational Study

    Jun 1, 2024, 00:00

  • EE491 Modeling Costs of Variations in Healthcare Utilization Following the COVID-19 Pandemic: Exploring How Model Choices and Fit Impact Interpretation

    Jun 1, 2024, 00:00

  • EPH35 Self-Reported Hypertension and the Likelihood of Aspirin Use and Associated Adverse Effects Among Adults Aged 18 Years and Older

    Jun 1, 2024, 00:00

  • PCR90 Patient Voice and Patient Engagement in Value Assessment Frameworks and HTA Decision-Making for Gene Therapies

    Jun 1, 2024, 00:00

  • RWD144 Predictive Risk Score for Nonalcoholic Steatohepatitis (NASH) Among Patients in the Department of Defense Population

    Jun 1, 2024, 00:00

  • RWD167 Clinical Utilization of Sodium-Glucose Cotransporter 2 Inhibitors in Systolic and Diastolic Heart Failure at a Large Academic Hospital

    Jun 1, 2024, 00:00

  • RWD147 Quantifying the Effectiveness of a RWD Quality Framework: A Case Study Using Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Jun 1, 2024, 00:00

  • CO57 Impact of Coexisting Mental Illnesses and Chronic Conditions on Healthcare Utilization and Cost at Blue Cross and Blue Shield of Louisiana

    Jun 1, 2024, 00:00

  • CO84 Racial/Ethnic Differences in Healthcare Resource Utilization Among Patients With Amyotrophic Lateral Sclerosis in Texas

    Jun 1, 2024, 00:00

  • RWD189 Exploration of Reason Codes in Real World Cardiovascular System Short-Term Disability Claims in the United States

    Jun 1, 2024, 00:00

  • EE326 Health Care Resource Utilization and Costs Among Patients with Paroxysmal Nocturnal Hemoglobinuria Initiating Eculizumab and Ravulizumab: A U.S. Claims Analysis

    Jun 1, 2024, 00:00

  • Novel Outcomes Research Data Methods

    Jun 1, 2024, 00:00

  • Study Approaches

    Jun 1, 2024, 00:00

  • CO140 Heterogeneous Treatment Effects of an Intensive Lifestyle Intervention: Evidence From the Look Ahead Study

    Jun 1, 2024, 00:00

  • HSD47 Treatment Response, Healthcare Resource Use, and Economic Outcomes Associated With Tumor Necrosis Factor Inhibitor Cycling Versus Switching to an Advanced Therapy With Different Mechanism of Action in Rheumatoid Arthritis

    Jun 1, 2024, 00:00

  • EE124 Real-World Mental Health Burden in Patients With Chronic Lymphocytic Leukemia

    Jun 1, 2024, 00:00

  • MSR30 Use of Natural Language Processing to Augment Real-World Data (RWD) and Identify Eligible Patients at Scale for Oncology Studies

    Jun 1, 2024, 00:00

  • EE94 End-of-Life Costs Among Older Adults Living with HIV

    Jun 1, 2024, 00:00

  • EE335 Burden of Disease in Patients Who Are Eligible for Bcma-Targeted Immunotherapy for Multiple Myeloma: A Retrospective Claims Database Analysis

    Jun 1, 2024, 00:00

  • MT14 Assessing the Association Between Cardiovascular Acoustic Biomarkers and Heart Failure: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • PCR30 An Investigation of Patient Journey Assessment in Rare Disease

    Jun 1, 2024, 00:00

  • PCR164 Exploring Symptom Burden, Treatment Bother, Physical Function, and Quality of Life By Frailty Status in Patients with Colorectal Cancer (CRC)

    Jun 1, 2024, 00:00

  • RWD191 Real-World Ovarian Cancer Mortality Outcomes in a Brazilian Reference Women Healthcare Public Hospital

    Jun 1, 2024, 00:00

  • SA71 Evaluation of Disease Burden (COMORBIDITIES, LENGTH OF HOSPITALIZATION AND HEALTHCARE RESOURCE UTILIZATION) from Respiratory Syncytial Virus (RSV) Illness in United Arab Emirates: A Retrospective Cohort Claims Database Study

    Jun 1, 2024, 00:00

  • PT1 Incorporating Stakeholder Perspectives Into Open-Source Model Building for Major Depressive Disorder

    Jun 1, 2024, 00:00

  • PCR19 Content-Related Validity of the Rand-36 Composite Scores with Other Patient-Reported Outcome Scales Among National Health and Wellness Survey Respondents in the United States, Japan, and 5 European Countries

    Jun 1, 2024, 00:00

  • HSD115 Rates of Follow-up Colonoscopy After Positive Stool-Based Screening Test for Colorectal Cancer

    Jun 1, 2024, 00:00

  • RWD73 Repurposing Statins to Reduce the Risk of Alzheimer's Disease and Related Dementias: A Machine Learning Approach for Causal Estimates

    Jun 1, 2024, 00:00

  • Pneumococcal Vaccination Strategies in 50-Year-Olds to Decrease Racial Disparities: A US Societal Perspective Cost-Effectiveness Analysis

    Jun 1, 2024, 00:00

  • EPH148 Bridging the Gap: Understanding Prostate Cancer Patient Characteristics in Clinical Trials

    Jun 1, 2024, 00:00

  • HPR148 Identifying and Addressing Social Determinants of Health: A Health System Specialty Pharmacy Approach

    Jun 1, 2024, 00:00

  • PCR33 Study of the Effects of a 12 Week Functional Exercise Programme in the Hungarian Adult Population

    Jun 1, 2024, 00:00

  • PCR114 Young People’s Barriers and Facilitators of Engagement With Web-Based Mental Health Interventions for Anxiety and Depression: A Qualitative Study

    Jun 1, 2024, 00:00

  • HSD86 Health Care Utilization before and during the COVID-19 Pandemic in Patients with Epithelial Ovarian Cancer

    Jun 1, 2024, 00:00

  • EE363 Economic Value of Early Genetic Testing in Inherited Retinal Dystrophy Diagnosis

    Jun 1, 2024, 00:00

  • MSR12 Use of Single Arm Studies/Disconnected Observational Studies in Comparative Effectiveness of Treatments for Fabry Disease: A Network Meta-Analysis Using a 3-Level Hierarchical Model

    Jun 1, 2024, 00:00

  • PCR262 The Use of Artificial Intelligence Chat To Improve Readability of Patient-Facing Materials

    Jun 1, 2024, 00:00

  • EPH225 Characteristics of Patients with Transthyretin Amyloidosis and Methodological Approaches for Establishing Clinical Subtype in the Netherlands

    Jun 1, 2024, 00:00

  • HPR41 One Step Away From the Abyss? Analysis of the Supplementary Health System in Brazil

    Jun 1, 2024, 00:00

  • HSD23 Preferences and Attitudes of Healthcare Providers (HCPs) and Adult Healthcare Consumers (HCCs) Towards Pneumococcal Conjugate Vaccines (PCVs) in the United States (US)

    Jun 1, 2024, 00:00

  • HPR112 Variation in Coverage of Specialty Therapies and Barriers to Fair Access

    Jun 1, 2024, 00:00

  • EPH157 Does COVID-19 Related Lockdown Restrictions Impact People With Musculoskeletal Disorders? A Systematic Review

    Jun 1, 2024, 00:00

  • EE452 Prevalence, Real-World Healthcare Resource Utilization, and Costs of Patients With Paroxysmal Nocturnal Hemoglobinuria in the US: A Retrospective Claims Database Analysis

    Jun 1, 2024, 00:00

  • PCR115 Health States Utilities for Allergic Rhinitis - an AI-Supported Systematic Review

    Jun 1, 2024, 00:00

  • HTA39 Long-Term Health-Related Quality of Life in Esophageal Cancer Survivors: A Literature Review

    Jun 1, 2024, 00:00

  • MSR87 A Method to Estimate Effect of Treatment Switching By Assigning Pseudo-Switch Date Among Continuers

    Jun 1, 2024, 00:00

  • MSR94 A Flexible, Likelihood-Based Method for Estimating Underlying Distributions, Mean and SD-Based on Reported Quantiles Such as Median and Inter-Quartile Range

    Jun 1, 2024, 00:00

  • CO189 Preliminary Outcomes of a Hearing Loss Screening Program of 5,360 Older Adults at the Medical University of South Carolina

    Jun 1, 2024, 00:00

  • The Relative Importance and Performance of Key Life Domains on Global Life Satisfaction in Early Adolescents

    Jun 1, 2024, 00:00

  • CO122 Real-World Data on Inequity in Clinical Outcomes Among Adult Patients Diagnosed with Hypertrophic Cardiomyopathy

    Jun 1, 2024, 00:00

  • RWD37 Demographic, Chronic Disease, and Health Care Utilization Characteristics of Patients Self-Reporting Economic Insecurity in a Large Midwest Health System

    Jun 1, 2024, 00:00

  • PCR243 Examining the Relevance of the SF-36v2 for Assessment in HDFN or FNAIT-Affected Pregnancies: Results of a Landscape Assessment and Clinician and Patient Interviews

    Jun 1, 2024, 00:00

  • PCR137 Within-Trial Interviews to Contextualize the Patient Experience and Supplement Clinical Outcomes Assessments in a Pivotal Trial of a Newly Described, Fatal and Ultra-Rare Pediatric Disease

    Jun 1, 2024, 00:00

  • RWD66 Lung Cancer Chemotherapy-Associated Clostridium Difficile Infection Among Elderly Patients in the United States

    Jun 1, 2024, 00:00

  • HPR130 Analysis of Forty-One Years of U.S. Food and Drug Administration Approvals, Regulatory Pathways, and Review Time of New Drugs and Biologics: A Retrospective Cohort Study

    Jun 1, 2024, 00:00

  • HPR70 Racial Disparity and Utilization of Disease-Risk Genetic Testing: A Nationwide Sampling Survey Analysis

    Jun 1, 2024, 00:00

  • RWD108 Demographics, Clinical Characteristics, and Treatment Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the US Across Social Determinants of Health (SDoH)

    Jun 1, 2024, 00:00

  • OP16 Analysis of Decision Factors and Recommendations for Incorporating Health Technologies in 6 HTA Agencies

    Jun 1, 2024, 00:00

  • PCR146 Real-World Multiple Myeloma Patient Experience By Frailty Status: Symptom Burden, Physical Function, Quality of Life, and Treatment Bother Captured from Electronic Patient-Reported Outcomes (ePROs)

    Jun 1, 2024, 00:00

  • EE35 Air Pollution-Related Health Disutility and Mitigation Policy Favorability Amongst California’s San Joaquin Valley Residents: A Health Economics Perspective on Equity

    Jun 1, 2024, 00:00

  • RWD112 Going Beyond Claims: Unleashing the Power of Diverse Healthcare Datasets in Clinical and HEOR Assessments

    Jun 1, 2024, 00:00

  • CO126 Competing Risks of Death in Older Adults With Advanced Non-Small Cell Lung Cancer Receiving Programmed Cell Death Protein 1 (PD-1) Inhibitors

    Jun 1, 2024, 00:00

  • HSD71 Implementing Patient-Reported Outcomes in Clinical Practi The PROTEUS-Practice Framework Guide

    Jun 1, 2024, 00:00

  • EE454 Economic Burden of Mild and Moderate Asthma in Adult Patients From Public Health Institutions Perspective in Mexico

    Jun 1, 2024, 00:00

  • EPH198 Analyzing the Impact of Colorectal Cancer Diagnosis on Treatment Adherence Amongst Patients With Preexisting Hypertension

    Jun 1, 2024, 00:00

  • PCR131 Treatment Continuity, Adverse Events and Psychiatric Hospitalization for Incident Users of Second-Generation Antipsychotics Long-Acting Injections in Schizophrenia: One-Year Follow-up Study

    Jun 1, 2024, 00:00

  • HPR69 State-Level Trends in Access to Medicaid Family Planning Services, 2008 – 2023

    Jun 1, 2024, 00:00

  • PCR187 Continuous Glucose Monitoring Adherence and Healthcare Costs in Adult Patients With Diabetes: Examining the Impact of Device Sourcing

    Jun 1, 2024, 00:00

  • MT35 Budget Impact Analysis of a Digital Intervention for Disease Management in Type 2 Diabetes

    Jun 1, 2024, 00:00

  • RWD106 Psychological Burden in People Living with Myasthenia Gravis: Prevalence and Associated Risk Factors of Depression and Anxiety from the MGFA Global MG Patient Registry (MGFAPR) in the US (2017-2022)

    Jun 1, 2024, 00:00

  • MSR4 Making the Case for Negative Control Outcome Studies in a Real-World Evidence (RWE) Setting

    Jun 1, 2024, 00:00

  • EPH209 Using Real-World General Practitioner Data To Study the Diagnosis and Management of Dementia: Rationale and Design

    Jun 1, 2024, 00:00

  • RWD10 Annual Health Insurance Treatment Cost of Female Infertility of Another Origin Based on Routinely Collected Financing Data between 2010-2019

    Jun 1, 2024, 00:00

  • EE467 Estimation of Budget Impact With the Substitution of Biologic Reference Product for Biosimilars in Patients With Rheumatoid Arthritis From the Perspective of Medium Size Healthcare Insurance in Brazil

    Jun 1, 2024, 00:00

  • PCR7 The Impact of Different Therapeutic Modalities (STANDARD TREATMENT, THROMBOLYSIS, THROMBECTOMY) on the Quality of Life of Stroke Patients

    Jun 1, 2024, 00:00

  • EE190 Budget Impact Analysis of Zanubrutinib + Obinutuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma in the United States

    Jun 1, 2024, 00:00

  • EE526 Predictors of Annual Eyewear Expenditures in the United States

    Jun 1, 2024, 00:00

  • RWD93 Obesity and Type 2 Diabetes: Analyzing Treatment Patterns and Socio-Economic Factors in Real-World Evidence

    Jun 1, 2024, 00:00

  • EE110 Leading Predictors of Medicare Payments Vary Across Different Phases of Care Among Older Hodgkin's Lymphoma Survivors: Application of Interpretable Machine Learning Models

    Jun 1, 2024, 00:00

  • HTA43 Alignment Between Health Technology Assessment (HTA) Requirements and Current Practices in Global Value Dossier (GVD) Development

    Jun 1, 2024, 00:00

  • HTA29 Improving Patient Access to New Health Interventions: Introduction of HTA for Medical Devices in Ukraine According to the Roadmap

    Jun 1, 2024, 00:00

  • EPH56 Validation of an Algorithm to Identify HR+/HER2- Metastatic Breast Cancer in Claims Data

    Jun 1, 2024, 00:00

  • HSD109 Association Between Routine Colorectal Cancer Screening and the Risk of Colorectal Cancer Diagnosed at Advanced Stage and Total Cost of Care Among US Adults

    Jun 1, 2024, 00:00

  • SA14 Validating Gestational Age ICD-10 Codes in Claims Data With Physician-Reported Gestational Age on Non-Invasive Prenatal Screening

    Jun 1, 2024, 00:00

  • HTA14 Payer Perspectives on the Use of ICER Evidence Reports Over the Past 24 Months

    Jun 1, 2024, 00:00

  • HPR19 Determining the Impact of Social Determinants of Health in the Prevalence of Diabetes in Mid-Atlantic Area

    Jun 1, 2024, 00:00

  • EPH207 Assessing Secular Trends in Cancer Stage at Initial Diagnosis in the United States Community Oncology Setting from 2015 to 2023

    Jun 1, 2024, 00:00

  • HSD20 Real-World Prescribing of Lecanemab in the United States

    Jun 1, 2024, 00:00

  • HSD108 Impacts of Long-Term Prescription Policy on Primary Care Utilization and Costs Among Hypertensive Patients in China: A Difference-in-Differences Analysis

    Jun 1, 2024, 00:00

  • CO28 Assessing Disparities in Cardiovascular Outcomes across Payers in Patients Diagnosed with Hypertrophic Cardiomyopathy

    Jun 1, 2024, 00:00

  • PCR256 Asthma Control Levels and Their Impact on Health Related Quality of Life (HRQoL) of Asthma Patients in Quetta, Pakistan

    Jun 1, 2024, 00:00

  • HSD42 Performance Assessment of a Disease-Agnostic Treatment Sequencing Heuristic for Deriving Line of Therapy (LOT) in a Real-World, Rare, Multi-Tumor Cohort across Tumor Mutational Burden (TMB) Status

    Jun 1, 2024, 00:00

  • Patient-Centered Research

    Jun 1, 2024, 00:00

  • HPR97 Strategic Implications for Biopharmaceuticals: Navigating the Medicare Price Negotiation Provisions of the Inflation Reduction Act

    Jun 1, 2024, 00:00

  • PCR230 Remote Symptom Alerts and Patient-Reported Outcomes (PROs) in Real-World Breast Cancer Practi Innovative Data to Derive Symptom Burden and Quality of Life

    Jun 1, 2024, 00:00

  • EPH60 Real-World Treatment Patterns in Adults with Pemphigus Vulgaris in the United States

    Jun 1, 2024, 00:00

  • EPH193 Validated Case-Identifying Algorithms Using Canadian Administrative Health Data: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • PCR102 Psychometric Validation of the Low Luminance Questionnaire (LLQ) in X-Linked Retinitis Pigmentosa (XLRP)

    Jun 1, 2024, 00:00

  • MSR71 Development of an Open-Source Web Application for Probabilistic Value-Based Contracting Performance Estimation

    Jun 1, 2024, 00:00

  • CO183 Real-World Clinical Outcomes and Genomic Profiles of Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) Harboring Both AR-LBD Missense Mutations and AR Copy Number Amplifications

    Jun 1, 2024, 00:00

  • EPH39 A Targeted Literature Review (TLR) of Clinical, Humanistic, and Economic Burden of Alzheimer’s Disease (AD) in the United States (US)

    Jun 1, 2024, 00:00

  • EE63 Cost-Effectiveness and Budget Impact of Pembrolizumab Monotherapy As the First-Line Treatment for Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 ≥ 50% in Thailand

    Jun 1, 2024, 00:00

  • RWD79 Evaluating the Impact of Anemia and Blood Transfusions on Patient Treatment Selection and Survival Rates for Patient With Myelofibrosis (MF) Using Real-World Data

    Jun 1, 2024, 00:00

  • RWD72 Decoding Medication Adherence, Mode of Prescription Filling, and Health Care Resource Utilization in Alzheimer’s: A Twelve-Month Analysis

    Jun 1, 2024, 00:00

  • CO209 Comorbidities in Myasthenia Gravis in the US National Veterans Affairs Health Network.

    Jun 1, 2024, 00:00

  • MSR39 Machine Learning Applications in Predicting the Onset of Psoriatic Arthritis: A Systematic Review

    Jun 1, 2024, 00:00

  • PCR15 Criteria for the Value Assessment for Medication Adherence-Enhancing Interventions

    Jun 1, 2024, 00:00

  • PCR246 Short-Term Quality of Life Assessment in Total Hip Arthroplasty Patients in Different Health Care Sectors

    Jun 1, 2024, 00:00

  • Clinical Outcomes

    Jun 1, 2024, 00:00

  • HPR13 A County-Level Deprivation Index for China in 2020 and Its Association With Life Expectancy and Infant Mortality

    Jun 1, 2024, 00:00

  • EE4 Should NICE Consider Adoption of a Societal Perspective? Comparison of the ICER 2023 Value Assessment Framework with the NICE 2022 Methods Guide

    Jun 1, 2024, 00:00

  • EE424 Societal Costs of Spinal Muscular Atrophy Type 1 for Patients Treated with Onasemnogene Abeparvovec or Nusinersen in the United Kingdom

    Jun 1, 2024, 00:00

  • PT35 Cost-Effectiveness Analysis of Nivolumab Versus Docetaxel for the Treatment of Advanced Nonsquamous NSCLC Including PD-L1 Testing in the United States

    Jun 1, 2024, 00:00

  • EE149 Economic Burden of Treating Chronic Peripheral Neuropathic Pain in the United States: National Estimates From 2022 Data

    Jun 1, 2024, 00:00

  • HTA72 Molnupiravir for Treatment of Non-Hospitalized Adults With Laboratory-Confirmed, Mild/Moderately Severe COVID-19: A Systematic Evidence Review With Meta-Analysis and Trial Sequential Analysis

    Jun 1, 2024, 00:00

  • EPH159 Burden of COVID-19 and Its Associated Clinical Characteristics in Colombia: A Retrospective Database Analysis

    Jun 1, 2024, 00:00

  • HPR76 Disparities in NMOSD Hospitalization Outcomes: A 5-Year Analysis of the Impact of Sociodemographic Factors on Healthcare Utilization and Charges

    Jun 1, 2024, 00:00

  • EE265 Treatment Patterns, Healthcare Resource Utilization and Costs, and Clinical Outcomes Among Elderly Patients With Advanced HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma

    Jun 1, 2024, 00:00

  • PCR59 Shaping the Value Equation in Digital Healthcare: A Case Study on Digital Neurorehabilitation

    Jun 1, 2024, 00:00

  • MSR32 Instrumental Variables to Address Non-Compliance in Randomized Control Trials: A Scoping Review

    Jun 1, 2024, 00:00

  • PCR167 Targeted Literature Review to Understand the Patient Experience of Essential Thrombocythemia and to Evaluate Existing Clinical Outcome Assessment Measures

    Jun 1, 2024, 00:00

  • RWD14 Healthcare Resource Utilization and Associated Costs in COPD Patients at High Risk of Exacerbation Despite Treatment With Dual or Triple Inhaled Therapy: Results From the Sirius Observational Study in the US

    Jun 1, 2024, 00:00

  • PCR17 Evaluation of Quality of Life and Its Predictors Among Breast Cancer Patients Accessing Care at a Tertiary Hospital in Nigeria

    Jun 1, 2024, 00:00

  • EPH102 Application of a Quasi-Experimental Study Design to Pharmacoepidemiology: An Evaluation of Immune Checkpoint Inhibitor Therapy and Cholangitis Using Real-World Data As a Case Study

    Jun 1, 2024, 00:00

  • EPH22 Epidemiology and Treatment Patterns of Colombian Patients With Metastatic Colorectal

    Jun 1, 2024, 00:00

  • EE34 JAV-RARAS: Methodological Aspects of Adherence Analysis to Clinical Protocols and Therapeutic Guidelines in Brazil

    Jun 1, 2024, 00:00

  • SA3 Quality of Systematic Literature Reviews of Health Economic Models

    Jun 1, 2024, 00:00

  • EE382 Effect and Economic Outcomes of the Polypharmacy Management System Platform for Common Diseases in the Elderly in China

    Jun 1, 2024, 00:00

  • P4 Is Later Diagnosis of Rare Diseases Associated with Higher Medical Costs? Real-World Evidence for Duchenne/Becker Muscular Dystrophy

    Jun 1, 2024, 00:00

  • RWD46 Real-World Clinical Burden of Friedreich Ataxia in the United States

    Jun 1, 2024, 00:00

  • RWD134 Learnings From Linking Closed Claims Patient Cohorts With Consumer SDOH Data

    Jun 1, 2024, 00:00

  • EE257 Management of Psoriasis and Atopic Dermatitis Costs in the Poor Insured Population of the Colombian Atlantic Coast

    Jun 1, 2024, 00:00

  • EE144 Chimerism Testing for Patients With Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Cost-Utility Analysis

    Jun 1, 2024, 00:00

  • EE117 Insights Into Sickle Cell Disease Hospitalizations and Outcomes: A Tale of 2 HCUP Databases

    Jun 1, 2024, 00:00

  • EE162 A Claims Analysis to Characterize the Economic Burden of Generalized Pustular Psoriasis Among Patients in the United States

    Jun 1, 2024, 00:00

  • MSR44 How Accurate Are Large Language Models for Abstract Screening in Systematic Literature Reviews?

    Jun 1, 2024, 00:00

  • RWD90 The Association Between Developing ADRD and Having a History of Depression: A Retrospective Cohort Study

    Jun 1, 2024, 00:00

  • HSD79 Evaluation of Real-World Treatment Patterns in Patients With Uncontrolled Gout in the USA

    Jun 1, 2024, 00:00

  • PCR72 Adherence of Treatment in Psoriasis- A Systematic Literature Review

    Jun 1, 2024, 00:00

  • EPH29 Prevention and Treatment in the Global Tuberculosis Epidemic: Approaches and Strategies in Current Clinical Trials

    Jun 1, 2024, 00:00

  • EPH96 Descriptive Statistics and Disease Prevalence from an Electronic Health Record Data Collective across 30+ US Health Systems

    Jun 1, 2024, 00:00

  • EPH115 Sex Differences on Limitations in Physical Functioning and Overall Quality of Life of People Living with Myasthenia Gravis from the MGFA Global MG Patient Registry (MGFAPR) in the US

    Jun 1, 2024, 00:00

  • PCR20 Assessing Activity Limitations Caused by Rheumatoid Arthritis to Inform Appropriate Selection of Patient-Reported Outcomes Measures

    Jun 1, 2024, 00:00

  • RWD180 Feasibility of Identifying Demographic and Clinical Insights for Patients with Chronic Kidney Disease from Real-World Data

    Jun 1, 2024, 00:00

  • EE263 Characterization of End-Stage Kidney Disease Patients With and Without Autosomal Dominant Polycystic Kidney Disease and Receiving Kidney Transplantation in the United States

    Jun 1, 2024, 00:00

  • EE121 Economic Consequences of Persistence and Adherence to Lifelong Therapy for Patients with Presymptomatic Spinal Muscular Atrophy (SMA)

    Jun 1, 2024, 00:00

  • PCR75 Unlock the Power of Plant-Based Diets: Integration into Public Education

    Jun 1, 2024, 00:00

  • PCR127 Patients' Preference in Intravitreal Treatment Options for Diabetic Macular Edema: Insights from Discrete Choice Experiment and Willingness to Pay

    Jun 1, 2024, 00:00

  • RWD74 Sex and Racial/Ethnic Disparities in Cardiovascular Disease Mortality Risk Among United States Cancer Patients

    Jun 1, 2024, 00:00

  • EE315 Cost-Effectiveness of Obicetrapib As Adjunctive Therapy Compared to Maximally Tolerated Statins for Lowering LDL-c

    Jun 1, 2024, 00:00

  • P55 Treatment and Outcomes in Metastatic Colorectal Cancer: A Causal Study Design Framework

    Jun 1, 2024, 00:00

  • PCR34 Higher Patient Activation Levels May Mitigate Alzheimer’s Caregiving Burden

    Jun 1, 2024, 00:00

  • PCR76 Exploring the Content and Psychometric Validity of Clinical Outcome Assessments in Renal Cell Carcinoma Versus the Patient Reported Symptoms and Impacts

    Jun 1, 2024, 00:00

  • PCR219 Disparities in Physical Function in Upper Limb Amputation: Influence of Race and Veteran Status

    Jun 1, 2024, 00:00

  • Costs and Productivity Benefits of the Department of Veterans Affairs Maintaining Internal Systems and Strengthening Integrated Outside Networks Act Scribes Trial

    Jun 1, 2024, 00:00

  • EPH133 Economic Burden of Invasive Meningococcal Disease in Individuals With Commercial and Medicare Insurance in the United States

    Jun 1, 2024, 00:00

  • MSR60 Addressing the Overlooked Inquiry in Feasibility Assessment of Network Meta-Analysis through the Covariate-Optimized Spatial Method for Integrated Clustering (COSMIC)

    Jun 1, 2024, 00:00

  • EE43 Understanding the Humanistic and Economic Burden Associated with Early-Stage HR+/HER2- Breast Cancer: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • HTA40 Nirmatrelvir/Ritonavir for Non-Hospitalized Adults With Mild/Moderately Severe COVID-19: A Systematic Evidence Review of Randomized Controlled Trials and Real-World Studies With Meta-Analysis and Trial Sequential Analysis

    Jun 1, 2024, 00:00

  • EPH125 Geographic Disparities in Chronic Kidney Disease Hospitalizations: Exploring Associations with Neighborhood Socioeconomic Status in Texas

    Jun 1, 2024, 00:00

  • HSD50 Time to Treatment Initiation By Diagnostic and Treatment Patterns Among Sarcoidosis Patients in a Real-World Hybrid Claims Database

    Jun 1, 2024, 00:00

  • PCR83 Comparison of Functional Status of Knee Replacement Patients with Individual and Serial Prostheses

    Jun 1, 2024, 00:00

  • MSR41 Unleashing the Power of Large Language Models: Using Zero-Shot Relevancy Classification on Social Media Posts for Enhanced Automated Understanding of Online Pet Owner Conversations About Canine Pruritus

    Jun 1, 2024, 00:00

  • SA75 Assessing the Value of Linking Abstracted Medical Record Data With Administrative Claims Data to Study Patients With High-Risk Non-Muscle Invasive Bladder Cancer in the United States

    Jun 1, 2024, 00:00

  • EE255 Costs and Healthcare Resource Utilization Evaluation in Myotonic Dystrophy Type 1: Results from the Real-World Care-DM1 Study

    Jun 1, 2024, 00:00

  • HSD59 Social Determinants of Health and Medication Adherence Among Older Adults With Chronic Conditions: Cross-Sectional Analysis of National Health and Nutrition Examination Survey (NHANES) 2009-2018

    Jun 1, 2024, 00:00

  • CO68 Performance Diagnostic Examination of Women's Handball Players

    Jun 1, 2024, 00:00

  • RWD170 Real-World Experience of Patients Newly Initiated on Pexidartinib for Tenosynovial Giant Cell Tumor

    Jun 1, 2024, 00:00

  • PCR118 Education and Employment Among Individuals with Duchenne Muscular Dystrophy: Results from a Caregiver Survey

    Jun 1, 2024, 00:00

  • PCR194 Examination of the Subjective Assessment of General Physical and Mental Health, Social Relationships, and Exercise Regularity Among Hungarian Football Players and Professionals during the Pandemic

    Jun 1, 2024, 00:00

  • PCR44 Real-DMD: Baseline Findings From an Electronic Observer-Reported Outcome (OBSRO) Survey of Long-Term Real-World Experiences of Patients with Duchenne Muscular Dystrophy (DMD)

    Jun 1, 2024, 00:00

  • CO159 Evaluating Risk of Complications in CAR-T Cell Therapy Among Patients with Acute Lymphocytic Leukemia

    Jun 1, 2024, 00:00

  • PCR184 Survey of Pregnant Women's Awareness and Compliance with Antenatal Care in the Light of Health Literacy

    Jun 1, 2024, 00:00

  • EE456 The Cost of Reusable Cystoscopy: A Microcosting Evaluation at a U.S. Academic Medical Center

    Jun 1, 2024, 00:00

  • EE470 The Impact of a Cost Savings Cap on the Cost Effectiveness of Valoctocogene Roxaparvovec for the Treatment of Hemophilia A in the United States

    Jun 1, 2024, 00:00

  • PCR94 A Systematic Literature Review of Quality-of-Life Outcomes in Posttraumatic Stress Disorder (PTSD)

    Jun 1, 2024, 00:00

  • Healthcare Simulation Modeling in HEOR

    Jun 1, 2024, 00:00

  • EPH186 Real-World Biomarker Prevalence and Treatment Patterns Among Metastatic Colorectal Cancer Patients Who Underwent NGS Testing

    Jun 1, 2024, 00:00

  • EE25 Economic Benefit of Faricimab Compared to Aflibercept 8mg in Treating Patients with Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the United States

    Jun 1, 2024, 00:00

  • HPR34 The Effect of Medical Insurance Outpatient Pooling Policy on Medical Service Utilization of Insured People: Evidence from CHARLS

    Jun 1, 2024, 00:00

  • EPH161 Estimation of the Size of the Eligible Population in the United States for Resmetirom: A Novel Investigational Therapy for NASH

    Jun 1, 2024, 00:00

  • EPH222 Trends of Mortality Related With Dengue in Colombia 2012-2021

    Jun 1, 2024, 00:00

  • HSD53 Community Oncologists’ Perceptions of Molecular Profiling: Insights into Precision Oncology Integration

    Jun 1, 2024, 00:00

  • EPH128 Identifying Diabetic Ketoacidosis Events at Diagnosis Among Type 1 Diabetes Patients in Claims Data

    Jun 1, 2024, 00:00

  • SA63 Comparative Analysis of Recurrence and Healthcare Expenditures After Primary Inguinal Hernia Repair Using Robotic-Assisted, Laparoscopic, and Open Surgical Approaches

    Jun 1, 2024, 00:00

  • HTA8 Identification of Cost-Effectiveness Evidence in UK NICE Single Technology Assessment Company Submissions: Databases, Sources and Currency of Searching

    Jun 1, 2024, 00:00

  • MT1 Health State Utility Value (HSUV) Elicitation in Medical Technology and Digital Health (DH): How Do They Compare to Pharmaceuticals? A Targeted Literature Review (TLR) of Interventions in Type 2 Diabetes Mellitus (T2DM)

    Jun 1, 2024, 00:00

  • CO198 Exploring Progression-Free Survival 2 (PFS2) Endpoint Trends and Uptake in the US Healthcare Landscape

    Jun 1, 2024, 00:00

  • HPR71 Successfully Remaining in Community for Home Health Care Patients With Alzheimer's Disease and Related Dementia: The Role of Living Arrangements and Rural Living

    Jun 1, 2024, 00:00

  • RWD102 Exploring the Potential of Real-World Data Sources in Oncology and Rare Diseases: A North American Perspective

    Jun 1, 2024, 00:00

  • PCR216 Exploring Quality of Life in Spinal Muscular Atrophy Patients through Vignette-Based EQ-5D-5L Measurements

    Jun 1, 2024, 00:00

  • HPR94 Clinical Trial Engagement in Hepatocellular Carcinoma: Understanding Demographic and Clinical Characteristics

    Jun 1, 2024, 00:00

  • SA46 Are We Dealing With Heterogeneity in Network Meta-Analysis Appropriately? A Review of NICE Submissions

    Jun 1, 2024, 00:00

  • EPH3 Potential Public Health Impact of Bivalent Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine (RSVpreF) Among Older Adults in Canada

    Jun 1, 2024, 00:00

  • RWD76 Prognosis of Myelodysplastic Syndrome Using De-Identified Market Clarity Database

    Jun 1, 2024, 00:00

  • RWD2 Comparison of Availability of New Cancer Medicines between Seven Countries

    Jun 1, 2024, 00:00

  • EE152 Cost-Effectiveness Analysis of Infliximab Versus Cyclosporine in Steroid-Refractory Acute Severe Ulcerative Colitis

    Jun 1, 2024, 00:00

  • HPR49 Real World Evidence and Rare Disease Considerations Across Regulatory and Health Technology Assessment Frameworks in the US, UK, and Canada

    Jun 1, 2024, 00:00

  • EPH109 The Effect of Metformin Adherence on the Reduction of Fracture Risk Among Type 2 Diabetes Patients

    Jun 1, 2024, 00:00

  • PCR67 Exploring the Link Between Genomic Testing Decisions and Quality of Life When Diagnosing Rare Childhood Disorders: A Sequential Stated Choice Experiment

    Jun 1, 2024, 00:00

  • PCR153 Psychometric Evaluation of the Allergan Satisfaction with Treatment Experience Questionnaire (ASTEQ) Using Data from a Phase 3B Study of an Intraocular Implant for Open-Angle Glaucoma (OAG) and Ocular Hypertension (OHT)

    Jun 1, 2024, 00:00

  • PCR172 Patient-Reported Outcomes in Non-Small Cell Lung Cancer: Psychometric Evaluation of the PROMIS PF-SF 8C and NSCLC-SAQ in Phase 3 Clinical Trials

    Jun 1, 2024, 00:00

  • HTA64 Characteristics of Cell and Gene Therapies Authorized By the Food and Drug Administration and the European Medicines Agency

    Jun 1, 2024, 00:00

  • EE84 Budget Impact of Factor VIII Treatments for Hemophilia A in the United States

    Jun 1, 2024, 00:00

  • Methodological Statistical Research

    Jun 1, 2024, 00:00

  • RWD60 Evaluating Trends in the Use of RWE in FDA New Drug Approvals

    Jun 1, 2024, 00:00

  • MT28 Perspectives for Innovative Medtech Production in Ukraine: Challenges and Opportunities

    Jun 1, 2024, 00:00

  • EE413 Predictive and Interpretable Machine Learning of Economic Burden: The Role of Chronic Conditions Among Patients with Incident Primary Merkel Cell Carcinoma

    Jun 1, 2024, 00:00

  • EE256 Cost-Effectiveness of Ferric Carboxymaltose in the Treatment of Iron-Deficiency Anemia in Pregnant Women

    Jun 1, 2024, 00:00

  • HTA50 A Review of Real-World Evidence in Non-Oncology Submissions Made to Four Health Technology Assessment (HTA) Agencies

    Jun 1, 2024, 00:00

  • EPH110 Real-World Treatment Patterns in Adults Living With Primary Chronic Immune Thrombocytopenia in the United States

    Jun 1, 2024, 00:00

  • HPR48 Factors Associated With Drug Overdose Mortality Rate in California

    Jun 1, 2024, 00:00

  • EPH203 Cytomegalovirus Prevalence in Allogeneic Hematopoietic Stem Cell Transplant Recipients From a Mexican Oncologic Reference Center

    Jun 1, 2024, 00:00

  • CO79 In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States: How Did It Change in 2022 and 2023?

    Jun 1, 2024, 00:00

  • EPH68 Baseline Characteristics of Pediatric and Adult Patients with ADHD Prescribed Viloxazine ER, Stimulants or Atomoxetine, in Open Claims Data

    Jun 1, 2024, 00:00

  • EE199 Budget Impact Analysis of the Anti-Vegfs Injections for Treating Diabetic Macular Oedema: Assessing Their Affordability in the UK Healthcare System

    Jun 1, 2024, 00:00

  • CO168 Association between Initial Propranolol Dose and Blood Pressure Control in 48 to 72 Hours Among Preterm Infants with Hypertension

    Jun 1, 2024, 00:00

  • CO36 Evaluating the Impact of State Level Masking Policies on Adherence over Time in Diabetic and Hypertensive Populations

    Jun 1, 2024, 00:00

  • PCR24 Exploring the Content and Psychometric Validity of Clinical Outcome Assessments in Pancreatic Ductal Adenocarcinoma Versus the Patient Reported Symptoms and Impacts

    Jun 1, 2024, 00:00

  • RWD50 Progression-Free Survival after First-Line Treatment in Endometrial Cancer Patients: A Real-World Perspective from Brazil and Argentina

    Jun 1, 2024, 00:00

  • EE520 Cost-Effectiveness of Tremelimumab Plus Durvalumab for the First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma in the United States

    Jun 1, 2024, 00:00

  • CO93 Impact of Caring for Persons with Schizophrenia: Review of Burden Assessment Measures

    Jun 1, 2024, 00:00

  • HSD75 Factors Associated With the Use of Immune Checkpoint Inhibitors in Older Adults With Metastatic Non-Small Cell Lung Cancer and Pre-Existing Autoimmune Disease: A SEER-Medicare Study

    Jun 1, 2024, 00:00

  • CO135 Comparative Efficacy, Safety, and Tolerability of KarXT Versus Aripiprazole and Cariprazine for the Acute Treatment of Adults With Schizophrenia: A Network Meta-Analysis

    Jun 1, 2024, 00:00

  • PCR36 Substantial Productivity Impairment in Patients With Essential Tremor

    Jun 1, 2024, 00:00

  • PCR254 Evidence To Support the Use of the Functional Assessment of Cancer Therapy – General Item GP5 (FACT-GP5) To Assess Comparative Tolerability Endpoint: Results From the LIBRETTO-531 Trial

    Jun 1, 2024, 00:00

  • SA29 Motivations and Barriers for Psychiatric Practice Adoption of Esketamine Nasal Spray for Treatment-Resistant Depression in the United States

    Jun 1, 2024, 00:00

  • SA73 Factors Affecting the Development Process of Health Tourism in Colombia: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • RWD149 Real-World Endometrial Cancer Mortality Outcomes at Brazilian Reference Women Healthcare Public Hospital

    Jun 1, 2024, 00:00

  • SA19 Mapping the Current Clinical Landscape for Alzheimer's Disease: A Qualitative Analysis

    Jun 1, 2024, 00:00

  • HPR133 Clinical Benefits of the Accelerated Approval Program in Oncology

    Jun 1, 2024, 00:00

  • MSR28 Use of Large Language Model (LLM) for Full-Text Screening in Systematic Literature Reviews: A Comparative Analysis

    Jun 1, 2024, 00:00

  • MT37 FDA-Approved Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices: An Updated Landscape from 1995 to 2023

    Jun 1, 2024, 00:00

  • EE275 Cost-Effectiveness Analysis of Biologics Used for the Treatment of Ankylosing Spondylitis in China

    Jun 1, 2024, 00:00

  • EPH106 Real-World Assessment of Cardiovascular Risk Factors Among Women with a Combined Hormonal Contraception Prescription in the United States: An Electronic Health Records Study

    Jun 1, 2024, 00:00

  • EE420 Development and Validation of a Markov Model for the Evaluation of a One-Time Universal Screening for Hepatitis B in Adults

    Jun 1, 2024, 00:00

  • PCR185 Health As a Value in University Students

    Jun 1, 2024, 00:00

  • EE283 Cost-Effectiveness Analysis of NRICM101 Compared to Usual Care for Treating COVID-19

    Jun 1, 2024, 00:00

  • EE294 Cost-Effectiveness Analysis of the Implementation of Single-Dose Vitamin D, Omega 3, or Co-Supplementation on Individuals with PCOS

    Jun 1, 2024, 00:00

  • EE319 Cost-Effectiveness of Assigning Early Interventions to Infants at High Risk for Autism Spectrum Disorder Using MRI Screening

    Jun 1, 2024, 00:00

  • MT13 Comprehensive Assessment for Breast Cancer Diagnosis Employing MATLAB Pre-Trained Models with Machine and Deep Learning

    Jun 1, 2024, 00:00

  • EE51 Analysis of Direct Costs of Treating Severe Hemophilia A in Brazil

    Jun 1, 2024, 00:00

  • PT11 Impact of the Inflation Reduction Act on Payer Utilization Management – Insights from a Quantitative Survey

    Jun 1, 2024, 00:00

  • HTA25 Benefit-Risk Assessment of Medical Products Using Bayesian Multi-Criteria Augmented Decision Analysis (MCADA)

    Jun 1, 2024, 00:00

  • EPH26 Claims-Based Analysis of the Prevalence, Characteristics, Healthcare Utilization, and Costs of Adolescents and Young Adults With Non-Remission Major Depressive Disorder in the United States, 2016-2022

    Jun 1, 2024, 00:00

  • PCR217 Diagnosing Preferences to Facilitate Shared Decision-Making: Development of a Novel Preference-Based Decision Support Tool for Adult Patients with Eosinophilic Esophagitis

    Jun 1, 2024, 00:00

  • EE391 Cost-Effectiveness of Radar: An Innovative Model to Organize Diabetes Care in First Nations Communities in Canada

    Jun 1, 2024, 00:00

  • HTA60 What Utilization Management Strategies Does ICER Recommend to US Payers and Policy-Makers to Manage Uncertainty with Gene Therapies?

    Jun 1, 2024, 00:00

  • SA59 Catalysts of Cost: Unveiling the Top Drivers of High-Cost Claims in Employer-Sponsored Healthcare Plans

    Jun 1, 2024, 00:00

  • CO201 Feasibility of Using Positron Emission Tomography–Computed Tomography (PET-CT) Scans From Real-World Medical Record Data to Support Lymphoma Treatment Response Assessment

    Jun 1, 2024, 00:00

  • RWD110 Group-Based Trajectory Modeling to Identify Longitudinal Patterns of Adherence to Oral Antidiabetic Medication in Older Adults on Concomitant Triple Therapy (Oral Antidiabetics, RAS Antagonists, Statins)

    Jun 1, 2024, 00:00

  • HSD54 Assessing the Impact of Telehealth Delivery on Adherence to Medications for Opioid Use Disorder

    Jun 1, 2024, 00:00

  • PCR158 Assessing the Cost of Work Productivity Loss in a Privately Insured US Population With Inflammatory Bowel Diseases

    Jun 1, 2024, 00:00

  • HSD67 A Retrospective Study Assessing Clinical and Economic Impacts of a Multidisciplinary Approach for Reducing Risk of Catheter-Related Thrombosis in a U.S. Health System

    Jun 1, 2024, 00:00

  • Epidemiology Public Health

    Jun 1, 2024, 00:00

  • CO89 Comparative Effectiveness and Safety of Abaloparatide and Teriparatide in the Treatment of Osteoporosis in Postmenopausal Women: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • PCR111 Real-World Evidence on Adherence to the First CDK 4/6 Inhibitor (Palbociclib) in Breast Cancer Patients From Romania

    Jun 1, 2024, 00:00

  • HSD6 The Role of Market Access Professionals in Pharmaceutical Industry: Document Analysis

    Jun 1, 2024, 00:00

  • HPR121 Impacts of National Drug Price Negotiation on Chronic Myeloid Leukemia Drugs Price, Volume and Spending in China

    Jun 1, 2024, 00:00

  • PCR100 Health-Related Quality of Life of Adolescents with Asymptomatic Convergence Insufficiency in China

    Jun 1, 2024, 00:00

  • EPH212 Assessing Intersectional Differences in Myocardial Infarction Among Same Race/Ethnicity Transgender and Cisgender Adults Using 2017-2022 Behavioral Risk Factor Surveillance System Data

    Jun 1, 2024, 00:00

  • HSD80 The Current Landscape of Anti-Obesity Medication Coverage Policies and Utilization Rates in the Unites States: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • EE92 Trends in Incidence and Economic Burden of Pneumonia in the United States from 2016-2021

    Jun 1, 2024, 00:00

  • HSD15 The Economic and Humanistic Burden of Glioma in the United States and Canada

    Jun 1, 2024, 00:00

  • HPR57 Use of External Control Arms in Novel Drug Approvals By U.S. Food and Drug Administration: A Targeted Review

    Jun 1, 2024, 00:00

  • Student Research in Economic Evaluation

    Jun 1, 2024, 00:00

  • EE109 BoNT-As for Adult Upper Limb Spasticity: Cost of Treatment and Response to Therapy in Canadian Patients

    Jun 1, 2024, 00:00

  • CO40 Zero Dollar Drug Co-Pay Program Increases Medication Adherence and Utilization Among Members With Diabetes in Louisiana

    Jun 1, 2024, 00:00

  • CO170 Real-World Survival Outcomes in Patients with Intermediate-to-High-Risk Non-Muscle Invasive Bladder Cancer Utilizing Medicare Claims Data: Estimating Event Free Survival and Evaluating Its Prediction of Overall Survival

    Jun 1, 2024, 00:00

  • HSD89 The Impact of Social Economic Status on Biologic Treatment Disparity in Inflammatory Bowel Disease

    Jun 1, 2024, 00:00

  • CO18 Impact of Empiric Treatment Failure on Healthcare Resource Utilization and Costs Among Females With Uncomplicated Urinary Tract Infections in a US-Based Integrated Health Delivery Network

    Jun 1, 2024, 00:00

  • CO52 Treatment History, Healthcare Resource Use, and Costs Among Patients With Pulmonary Arterial Hypertension (PAH) Initiating Treatment With Macitentan: A Retrospective Claims Analysis

    Jun 1, 2024, 00:00

  • CO196 Saturation Reporting in COA Development and Validation Studies: A Scoping Overview

    Jun 1, 2024, 00:00

  • SA48 Methods to Account for the Impact of COVID-19 in Real-World Retrospective Studies of Economic Outcomes: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • HPR37 Racial Disparities in Homologous Recombination Repair (HRR) Biomarker Testing in the United States: A Real-World Database Analysis Among White and Non-White Patients with Metastatic Prostate Cancer

    Jun 1, 2024, 00:00

  • RWD135 Right-Sided vs Left-Sided Colorectal Cancer Hospitalization Outcomes in the US

    Jun 1, 2024, 00:00

  • CO162 Systematic Literature Review (SLR) and Meta-Analysis of Crizotinib Versus Conventional Chemotherapy in First-Line Treatment for ROS-1 Rearranged Non-Small Cell Lung Cancer

    Jun 1, 2024, 00:00

  • HPR27 Optimizing Drug Market Exclusivity in the US and EU Markets

    Jun 1, 2024, 00:00

  • RWD57 Trends and Factors Affecting the Initiation of Denosumab and Zoledronic Acid Among Metastatic Lung, Breast, and Prostate Cancer Patients in the United States

    Jun 1, 2024, 00:00

  • Economic Evaluation

    Jun 1, 2024, 00:00

  • MSR25 An Assessment of ChatGPT's Ability to Code for Different Statistical Packages

    Jun 1, 2024, 00:00

  • PCR267 Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Quality of Life

    Jun 1, 2024, 00:00

  • SA23 Selection of Characteristics for Matching Adjusted Indirect Comparison in a Functional Mitral Regurgitation Population

    Jun 1, 2024, 00:00

  • CO194 Evaluating the Clinical Phenotypes Associated with Progression to Chronic Kidney Disease Using an Unsupervised Machine Learning Approach

    Jun 1, 2024, 00:00

  • OP6 Plain Language Summaries in Medical Journals – How Accessible Is Scientific Research to the General Public?

    Jun 1, 2024, 00:00

  • HPR60 Use of Brand-over-Generic Preferred Drugs in Medicaid Programs

    Jun 1, 2024, 00:00

  • HSD19 Provider Perceptions of Barriers to Biosimilar Utilization in Community Oncology Practices

    Jun 1, 2024, 00:00

  • SA74 Trends in Publication of Budget Impact and Cost Utility Analyses from 2000-2022 in the United States

    Jun 1, 2024, 00:00

  • EE286 Japan-Specific Risk Equations for Modeling Diabetes in the Japanese Setting: Does It Make a Difference?

    Jun 1, 2024, 00:00

  • EPH145 Feasibility of a Network Meta-Analysis Assessing Relative Effectiveness and Safety of Remdesivir Versus Other Treatments for COVID-19 Inpatients

    Jun 1, 2024, 00:00

  • EE243 Targeted Literature Review of Cost-Effectiveness Analyses in Sickle Cell Disease: Identifying the Optimal Modeling Approach for Therapies Targeting Sickle Hemoglobin Polymerization

    Jun 1, 2024, 00:00

  • PCR82 Fostering Peer-Reviewed Publication of Patient Engagement Activities: Multistakeholder Perspectives on Priorities, Motivators and Challenges

    Jun 1, 2024, 00:00

  • RWD132 Do Generic Population Utility Scores Accurately Represent Real-World Experienced Health?

    Jun 1, 2024, 00:00

  • RWD104 Disease and Treatment Characteristics of Hodgkin's Lymphoma from Social Media Data: Application of Name Entity Recognition Natural Language Processing

    Jun 1, 2024, 00:00

  • Clinical Outcomes

    Jun 1, 2024, 00:00

  • SA67 Demographic and Clinical Characteristics of Patients Who Delayed, Skipped, or Continued Care During the First Year of the COVID-19 Pandemic and the Study Design Implications

    Jun 1, 2024, 00:00

  • CO48 A Non-Interventional Chart Review Study of Infliximab Precision-Guided Dosing Tool's Clinical Experience Program: Interim Analysis of Real-World Health Outcomes and Extrapolated Cost Savings

    Jun 1, 2024, 00:00

  • HSD87 Determinants of Innovative Drugs' Adoption: Evidence from Lithuania

    Jun 1, 2024, 00:00

  • SA5 A Scoping Review of Barriers and Facilitators to Implementation of Intravenous Cardiovascular Treatments in Ambulatory Settings

    Jun 1, 2024, 00:00

  • PCR96 Exploring Patient Preferences through Cross-Sectional Discrete Choice Experiment: An Insight into Once-Daily Stroke Prevention Treatments in Atrial Fibrillation in Asia

    Jun 1, 2024, 00:00

  • CO191 Improving Shooting Accuracy and Center of Gravity with Closed Kinematic Chain Exercises in Handball Players

    Jun 1, 2024, 00:00

  • EPH118 Reduction of Adolescent Pregnancy and the Increase in Intrauterine Device Insertion: Data from a Private Health Insurance Company in Brazil

    Jun 1, 2024, 00:00

  • RWD24 Real-World Evidence of the Clinical and Sociodemographic Characteristics of Patients with Atopic Dermatitis in Colombia: The Update Results of RENDAC

    Jun 1, 2024, 00:00

  • PCR223 Considerations for the Development of Treatment Efficacy/Benefit Attributes and Levels in Patient Preference Studies

    Jun 1, 2024, 00:00

  • RWD80 Identification and Characterization of Real-World Evidence Presented on Brand Websites for the Top 20 Medicines with the Highest CMS Expenditure

    Jun 1, 2024, 00:00

  • MSR21 Development and Application of a Framework for Addressing New Challenges of Missing Data in Real-World Research

    Jun 1, 2024, 00:00

  • MSR42 Advancing Meaningful Change: Generating between-Group and within-Person Thresholds for the Asthma Daytime and Nighttime Symptom Diaries

    Jun 1, 2024, 00:00

  • RWD21 Assessing Dementia: An Analysis of Cognitive Scores, Pharmacy Costs, and Medication Adherence Using Unstructured and Structured Data

    Jun 1, 2024, 00:00

  • Cover

    Jun 1, 2024, 00:00

  • CO205 Impact of GLP-1A Treatment on Eating Disorder Inciden A Comparative, Real World Data Study in Patients With and Without Pre-Existing Mental Health Conditions

    Jun 1, 2024, 00:00

  • RWD11 Clinical and Humanistic Burden Associated with Alzheimer's Disease in the United States: An Analysis of Patient Characteristics, Treatment Patterns, and Quality of Life Using a Physician Notes Real-World Database

    Jun 1, 2024, 00:00

  • EE372 Cost-Effectiveness Analyses of Continuous Renal Replacement Therapy (CRRT) System in Health Care System in LMIC/LATAM/Brazil

    Jun 1, 2024, 00:00

  • OP8 Justice-Informed Analysis: A Unified Framework for Increasing Inclusivity and Methodological Rigor in Health Inequities Research

    Jun 1, 2024, 00:00

  • CO171 Comparative Effectiveness of KarXT and Selective Second-Generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Literature Review and Network Meta-Analysis

    Jun 1, 2024, 00:00

  • EPH196 A Claims-Based Analysis of Weight Management in Pediatric Populations Covered By Commercial or Medicaid Insurance

    Jun 1, 2024, 00:00

  • EPH49 Prevalence and Incidence of ROS1 and NTRK Rearrangements in Real-World Patients With Advanced Non–Small Lung Cancer in the United States

    Jun 1, 2024, 00:00

  • RWD39 Validating the Utility of Synthetic Data Generation for Clinical Research

    Jun 1, 2024, 00:00

  • EE57 Missed Opportunities? Gaps in Capturing the Full Value of Vaccination Across Health Economic Studies of COVID-19 Vaccination

    Jun 1, 2024, 00:00

  • HPR101 Impacts of the CDC’s 2016 Guideline for Prescribing Opioids for Chronic Pain on Opioid Prescribing and Pain Management Outcomes: A Systematic Review

    Jun 1, 2024, 00:00

  • HTA20 Population Adjusted-Indirect Comparisons in Health Technology Assessment: A Methodological Systematic Review

    Jun 1, 2024, 00:00

  • CO112 A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of Ruxolitinib Cream 1.5% Vs Other Pharmacologic Agents in the Treatment of Atopic Dermatitis (AD)

    Jun 1, 2024, 00:00

  • EE342 Development of a Markov Model for Assessing the Cost-Effectiveness of Chronic Weight Management Interventions

    Jun 1, 2024, 00:00

  • PCR14 Development and Validation of Two New Patient-Reported Outcome Measures for Recurrent Urinary Tract Infection: The Recurrent UTI Symptom Scale (RUTISS) and the Recurrent UTI Impact Questionnaire (RUTIIQ)

    Jun 1, 2024, 00:00

  • EPH199 Social Determinants of Health Associated with Delayed Medical Care in an Online Health Community

    Jun 1, 2024, 00:00

  • HPR17 Exploring Financing Models for CAR-T Cell Therapies in Global Healthcare Systems: A Comprehensive Scoping Review

    Jun 1, 2024, 00:00

  • CO142 Predisposing, Enabling, and Need Factors Associated With Postpartum Depression Treatment Among Women Enrolled in Texas Medicaid

    Jun 1, 2024, 00:00

  • PCR265 Measurement of Health Insurance Literacy and Identification of Its Correlates Among Working-Age Cancer Survivors in the US

    Jun 1, 2024, 00:00

  • Epidemiology Public Health

    Jun 1, 2024, 00:00

  • RWD177 Treatment Pattern and Disease Burden of Severe Asthma: A Real-World Study Based on Claims Data in China

    Jun 1, 2024, 00:00

  • MSR72 An Evaluation of the Rayyan Artificial Intelligence Tool for Systematic Literature Review Screening

    Jun 1, 2024, 00:00

  • Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force [Editor's Choice]

    Jun 1, 2024, 00:00

  • MT38 Electromagnetic Navigation Bronchoscopy (ENB) Versus Shape-Sensing Robotic-Assisted Bronchoscopy (ssRAB) Lung Navigation Platforms: A Cost-Minimization Analysis

    Jun 1, 2024, 00:00

  • CO131 Exploring Simplified Screening Cut-Offs: Classification of KCNQ2-DEE Patients into Age-Adjusted Disease Phenotypes

    Jun 1, 2024, 00:00

  • CO72 Investigating Regional Differences in Cardiovascular Outcomes Among Patients Diagnosed with Hypertrophic Cardiomyopathy

    Jun 1, 2024, 00:00

  • HPR108 The Patient Access Landscape for Rare Disease Medicines in Brazil: A Multi-Stakeholder Perspective

    Jun 1, 2024, 00:00

  • MT10 Higher SARS-CoV-2 Spike Antibody Levels Are Associated With Reduced Risk of Subsequent Symptomatic and Severe COVID-19: A Real-World Data Study

    Jun 1, 2024, 00:00

  • EPH71 Trend of Increase in the Use of Hormonal Intrauterine Devices in Women From a Health Insurance Company in Brazil: What Is the Explanation?

    Jun 1, 2024, 00:00

  • MSR93 Patient Cloning for Assessing Dynamic Treatment Protocols: A Novel Approach for Observational Data Analysis Using Real-World Data (RWD)

    Jun 1, 2024, 00:00

  • EE111 Optimization of the Health Economic Model of Type 2 Diabetes Based on Glycemic Variability Mechanism

    Jun 1, 2024, 00:00

  • PCR105 Does Availability of Rare Disease Treatment Improve Time to Diagnosis?

    Jun 1, 2024, 00:00

  • EE468 Cost-Effectiveness Study of the Use of Fibrinogen Concentrate (Clottafact®) in Patients with Major Bleeding and Trauma Requiring Surgery in Mexican Public Health Institutions

    Jun 1, 2024, 00:00

  • MSR16 Examining Fairness in Machine Learning Predictions of Healthcare Costs in Older Women With Osteoarthritis: XGBoost Regression

    Jun 1, 2024, 00:00

  • SA44 Association between Facilities of First COVID-19 Diagnosis and Previous Outpatient Visits Based on a Claims Database Analysis

    Jun 1, 2024, 00:00

  • PCR236 Analyzing Possible Diagnostic Delay Factors in Gynaecological and Andrological Diseases Among Secondary School Students

    Jun 1, 2024, 00:00

  • MT27 Comparison of Quality Parameters from Control Units Processed with Semi-Automated and Automated Processing Systems in the Colombian Blood Bank Hospital Pablo Tobón Uribe

    Jun 1, 2024, 00:00

  • CO25 Examining the Effectiveness of Rotator Cuff Training on Shoulder Joint Stability, Mobility and Shooting Accuracy Among Basketball Players

    Jun 1, 2024, 00:00

  • EPH6 Changes in the Midwives Density per 1,000 Live Births in Europe

    Jun 1, 2024, 00:00

  • RWD34 Examining Bias in the Narxcare Score: Unveiling Disparities in AI/ML Features for Opioid Prescribing Decisions

    Jun 1, 2024, 00:00

  • PCR229 Development of the ADHD Treatment Satisfaction Questionnaire (ATSQ) for Use with Children, Adolescents, and Their Caregivers

    Jun 1, 2024, 00:00

  • CO1 The Rate of Ward to Intensive Care Transfer and Its Predictors Among Hospitalized COPD Patients: A Retrospective Study in a Local Tertiary Center in Saudi Arabia

    Jun 1, 2024, 00:00

  • EE429 Optimizing Multicancer Early Detection (MCED) Testing Based on Patient Stratification: A Comprehensive Analysis of Economic and Clinical Impact from a US Payer Perspective

    Jun 1, 2024, 00:00

  • CO87 The Patient Journey of Bariatric Surgery – a Study Comparing the Healthcare and Medication Utilization before and after the Bariatric Surgery

    Jun 1, 2024, 00:00

  • EE355 Can Large Language Models Generate Conceptual Health Economic Models?

    Jun 1, 2024, 00:00

  • CO163 Impact of Glucocorticoid Use on Mortality in Adults with Chronic Diseases: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • HPR53 How Does the Inclusion of New Drugs in National Reimbursement Drug List Influence Health Outcomes and Financial Burden for Multiple Sclerosis Patients

    Jun 1, 2024, 00:00

  • MSR37 Methodological Review on Delphi Technique: Expert Definition and Retention in Rare Diseases

    Jun 1, 2024, 00:00

  • EE392 Number Needed to Treat (NNT) Comparing Sacituzumab Govitecan and Single-Agent Chemotherapy in Relapsed or Refractory Metastatic Triple-Negative Breast Cancer

    Jun 1, 2024, 00:00

  • RWD56 Expert Consensus on Diagnosis, Risk Stratification, and Treatment of Smoldering Multiple Myeloma: Results From a Multinational Delphi Panel Study

    Jun 1, 2024, 00:00

  • RWD59 Determinants of Smoking Cessation Program Completion and Continued Tobacco Use in a Referral Program: An EHR Data Analyses From 2018-2023

    Jun 1, 2024, 00:00

  • EPH95 Leveraging Data Aggregators to Annotate Deidentified Genomic Data Derived from Commercial Laboratory Specimens to Study COVID-19 Severity

    Jun 1, 2024, 00:00

  • EPH21 Burden of Unresectable/Metastatic Melanoma(u-mMel) and Advanced/Metastatic Colorectal Cancer(mCRC), and Their Associated BRAF-mutations in Four LATAM Countries: A Targeted Literature Review of Epidemiological and Economic Evidence

    Jun 1, 2024, 00:00

  • P10 Using the Health Improvement Distribution Index to Inform Equitable Machine Learning: An Example Analysis Among Patients with Type 2 Diabetes Mellitus

    Jun 1, 2024, 00:00

  • MSR43 Identifying Eligibility for Chimeric Antigen Receptor T-Cell Therapy Among Diffuse Large B-Cell Lymphoma Patients Using Real-World Data and Unsupervised Machine Learning

    Jun 1, 2024, 00:00

  • CO178 Access to Preventive Care and Social Determinants of Child Obesity: A Retrospective Cohort Study Using the Pinc AI™ Healthcare Database (PHD)

    Jun 1, 2024, 00:00

  • RWD26 Tokenization-Linked Social Determinants of Health (SDoH) Data: A Gateway to Enhanced Understanding of Rare Disease Clinical Trial Populations

    Jun 1, 2024, 00:00

  • HTA67 Assessing Relationships Between the Canadian Agency for Drugs and Technologies in Health (CADTH) Revised ICERs and Unmet Need, Clinical Benefit, Price Reductions, and Listing Negotiation Timelines

    Jun 1, 2024, 00:00

  • P8 Projections of Costs and Prevalence of Opioid Drug Prescriptions in the U.S. from 2025 - 2050

    Jun 1, 2024, 00:00

  • CO60 A Vocation for Life on Land, Sea and Air - Health Assessment of Ambulance Workers

    Jun 1, 2024, 00:00

  • PCR245 Patient Characteristics and Improved Outcomes With Greater Adherence to Acthar® Gel in Nephrotic Syndrome

    Jun 1, 2024, 00:00

  • HPR33 Short- and Long-Term Impacts of the National Essential Medicines Policy on Drug in Rural China

    Jun 1, 2024, 00:00

  • HTA2 A Comparison of NICE Timelines for Highly Specialised Technology Submissions and Resubmissions

    Jun 1, 2024, 00:00

  • SA4 Missingness Patterns in a Survey of Barriers to Care Among Individuals Diagnosed With Cancer: An Exploratory Analysis

    Jun 1, 2024, 00:00

  • EPH195 Social and Political Correlates of Geographic Disparities in HIV and Cardiovascular Medication Utilization

    Jun 1, 2024, 00:00

  • EE447 Evaluating the Impact of Disease Prevalence and Product Administration on Launch Pricing Trends for Non-Oncology Orphan Products

    Jun 1, 2024, 00:00

  • MT34 The Impact of the Use of a Digital Diabetes Management Application on HCRU-Related Costs and Pharmacy Claims in Patients With Type 2 Diabetes Mellitus

    Jun 1, 2024, 00:00

  • HPR152 The Impact of Insurance Reform on Health Resource Utilization and Persistence for Chinese Patients With Crohn’s Disease, Taking Ustekinumab as an Example: Evidence From a Natural Experiment Study

    Jun 1, 2024, 00:00

  • PT7 Engaging Patients With Rare Disease in Identifying Meaningful Approaches to Integrate Patient-Centered Outcomes in Comparative Effectiveness Research and Value Assessment

    Jun 1, 2024, 00:00

  • EE52 The Burden of Intravenous vs Subcutaneous Oncological Products Application in Honduras

    Jun 1, 2024, 00:00

  • EE197 The Impact of Funding Tocilizumab for the Inpatient Treatment of COVID-19 in the United States: A Distributional Cost-Effectiveness Analysis

    Jun 1, 2024, 00:00

  • CO83 Screening Articles in a Qualitative Literature Review Using Large Language Models: A Comparison of GPT Versus Open Source, Trained Models Against Expert Researcher Screening

    Jun 1, 2024, 00:00

  • CO51 Effect of Donated Plasma on Laboratory Parameters and Motivating Factors of Donated Plasma

    Jun 1, 2024, 00:00

  • HTA70 Early Patient Access to Life Saving Drugs across Europe – A Review of the Characteristics and Availability of Drugs in Early Access Programs in EU4 and the UK

    Jun 1, 2024, 00:00

  • EE163 Impact of Slowing Alzheimer’s Disease (AD) Progression: A Simulation Model in a Population of Patients with Early AD in the United States

    Jun 1, 2024, 00:00

  • EE175 Economic Burden of Pneumococcal Disease Among US Children — A Review of Cost-Effectiveness Analyses of Pneumococcal Vaccines

    Jun 1, 2024, 00:00

  • SA9 Validation of a Claims-Based Algorithm to Identify Major Congenital Malformations in Infants Using a Linked Claims-EMR Database

    Jun 1, 2024, 00:00

  • CO175 Quality of Life and Productivity Loss Cost Associated with Low Back Pain By Severity in Korea

    Jun 1, 2024, 00:00

  • EE9 Economic Burden of Gaucher Disease in Colombia

    Jun 1, 2024, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8 (current)
  • 9
  • 10
  • »